Steven Gilman

Steven Gilman

Direttore/Membro del Consiglio presso SCYNEXIS, INC.

Patrimonio netto: 166 250 $ in data 31/05/2026

73 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Steven C.
Gilman
is an Independent Director at SCYNEXIS, Inc. since 2015.
Holds Director positions at the Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Former roles include Vice Chairman at ContraFect Corp.
from 2019 to 2023; Chairman & Chief Executive Officer at ActivBiotics, Inc. from 2006 to 2007; Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018; Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2026; Independent Director at Vericel Corp.
from 2015 to 2025; Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC from 2010 to 2015; Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc. from 2000 to 2004; Executive Director at Inhibikase Therapeutics, Inc. from 2014 to 2016; Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc.; Group Director-Global Research & Development at Pfizer (St. Louis); Director at Massachusetts Biotechnology Council, Nextcea, Inc., and other firms; Scientist at Wyeth LLC; Principal at Connecticut College and Temple University School of Medicine; General Manager at Inflammation Research Association, Inc. Education includes undergraduate studies at Miami University and graduate and doctorate degrees from The Pennsylvania State University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
10/06/2025 152.830 ( 0,06% ) 155 887 $ 31/05/2026
01/04/2026 14.700 ( 0,02% ) 10 364 $ 31/05/2026

Posizioni attive di Steven Gilman

SocietàPosizioneInizio
SCYNEXIS, INC. Direttore/Membro del Consiglio 25/02/2015
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 07/07/2009
Direttore/Membro del Consiglio -

Precedenti posizioni note di Steven Gilman

SocietàPosizioneFine
AKEBIA THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/04/2026
VERICEL CORPORATION Direttore/Membro del Consiglio 30/04/2025
CONTRAFECT CORPORATION Amministratore Delegato 02/04/2019
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Steven Gilman

Formazione di Steven Gilman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

65

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

  1. Mercati
  2. Insiders
  3. Steven Gilman
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA